SOX2 and non-small cell lung carcinoma: Besides, chelerythrine was identified to down-regulate the level of β-catenin and inhibited CSC invasion, spheroid formation and the expression of the stem marker SOX2 in non-small cell lung carcinoma (NSCLC) [149, 150].